ALFA FinderNSE filing, NSE: BETA. Summary written from the filing by ALFA Finder's alert engine.
Beta Drugs Ltd: key numbers
- Share price
- ₹1,878.30
- Market cap
- ₹2,082 Cr
- Revenue (annual)
- ₹384.8 Cr
- Net profit (annual)
- ₹41.48 Cr
- P/E (TTM)
- 40.1×Sector 43.8×
- Promoter holding
- 58.91%-0.19% QoQ
- FII holding
- 1.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Beta Drugs Ltd
All →Beta Drugs Other Announcement
Beta Drugs Limited submitted its quarterly Statement of Deviation or Variation for the preferential issue proceeds, confirming no deviation from the stated objects.
Beta Drugs Earnings Call Transcript: Key Takeaways
Management projects a 20-25% growth trajectory despite Q2 bottlenecks. Recent acquisitions and niche oncology focus underpin expansion strategy.
- Call
- Guides 25% growth
Beta Drugs Investor Presentation: Key Takeaways
Beta Drugs reported H1 FY27 revenue of INR 263 Cr with EBITDA margins expanding to 23.2%. The firm is transitioning from a CMO to a branded specialty oncology powerhouse.
Beta Drugs Q2 FY27 Results: Net Profit ₹18.55 Cr, Up 51.8% YoY
Beta Drugs Ltd reported revenue from operations of ₹137.5 Cr (+33.0% YoY) and net profit of ₹18.55 Cr (+51.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹18.55 Cr · +51.8% YoY
Beta Drugs Board Meeting Date
Beta Drugs Limited notified the exchange of a board meeting scheduled for 22-Oct-2026 to consider quarterly financial results. The trading window closure was also intimated.
Beta Drugs Annual General Meeting
Beta Drugs Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders considered resolutions including financial statement adoption, director re-appointments, and auditor ratification.
Other other announcement announcements
All →Vectras Enprocon Other Announcement
Director Ravi P Patel bought 12,000 Vectras Enprocon shares for Rs. 0.13 Crore on BSE. No promoter involvement in this routine market purchase.
- Value
- ₹0.13 Cr
LGT Global Hospitality Other Announcement
LGT Global Hospitality filed its quarterly Monitoring Agency Report for Q1 FY27 under ICDR 162A. The report confirms Nil deviation in utilisation of its ₹21.92 crore IPO proceeds.
Astra Microwave Products Other Announcement
Astra Microwave filed a Reg 32 statement for the quarter ended September 30, 2026. It confirms no deviation or variation in the use of preferential-issue warrant proceeds.
Rane Holdings Other Announcement
Rane Holdings filed its Q1 FY27 Reg 32 statement on use of preferential-warrant proceeds. It reported ₹10 Cr raised and ₹7.81 Cr utilised for borrowings, with no deviation.
PS IT Infrastructure & Services Other Announcement
PS IT Infrastructure shifted its registered office to Laxmi Plaza, Andheri West, Mumbai effective 11 Nov 2026. No business or financial impact follows from this administrative change.
Krishca Strapping Solutions Other Announcement
Krishca Strapping Solutions notified NSE of a delay in H1 FY27 unaudited results due to an ERP system migration. Results are expected within one week of the 12 Nov 2026 intimation.